Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Phase II Study of Temsirolimus (CCI-779), a Novel Inhibitor of mTOR, in Heavily Pretreated Patients With Locally Advanced or Metastatic Breast Cancer
PaperCitations, authors & open-access status
Phase II Study of Temsirolimus (CCI-779), a Novel Inhibitor of mTOR, in Heavily Pretreated Patients With Locally Advanced or Metastatic Breast Cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 469 citations, 2005 year and bronze oa status.
469
Citations
2005
Year
bronze
OA Status